$4.53
-0.27-5.62%
Last update: Oct 26, 4:00 PM
Evolent Health Inc
EVHNYSE
Evolent Health (EVH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Evolent Health (EVH) last issued guidance on August 6, 2026 for fiscal year 2026. The company guided revenue in the range of $2.6B - $2.7B for the period.
Compared to prior guidance, Evolent Health raised its revenue forecast from a prior range of $2.4B - $2.6B.
Evolent Health has issued 35 guidance updates between November 2, 2022 and August 6, 2026. During this period, the company raised its outlook 7 times and lowered it 12 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.07 | $0.02 | $0.11 |
| Actual | $0.02 | $-0.02 | $0.08 | $0.05 |
| Surprise | +166.7% | +71.4% | +300.0% | -54.5% |
| Revenue | ||||
| Estimate | $601.9M | $533.6M | $468.8M | $470.8M |
| Actual | $652.5M | $496.2M | $468.7M | $479.5M |
| Surprise | +8.41% | -7.00% | -0.01% | +1.85% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.04 | $0.13 | $-0.02 | $-0.04 |
| Revenue | ||||
| Consensus | $728.5M | $757.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.02 | $-0.03 | 166.7 % |
| Q1 | May 7, 2026 | $-0.02 | $-0.07 | 71.4 % |
| Q4 | Feb 24, 2026 | $0.08 | $0.02 | 300.0 % |
| Q3 | Nov 6, 2025 | $0.05 | $0.11 | -54.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $652.52M | $601.91M | 8.41 % |
| Q1 | May 7, 2026 | $496.25M | $533.59M | -7.00 % |
| Q4 | Feb 24, 2026 | $468.72M | $468.78M | -0.01 % |
| Q3 | Nov 6, 2025 | $479.53M | $470.82M | 1.85 % |
